The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

By McClements W.L.   Armstrong M.E.   Keys R.D.   Liu M.A.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 857-860

Elsevier

Access to resources Recommend Favorite

Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection

By Bernstein D.I.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1351-1358

Elsevier

Access to resources Recommend Favorite

Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems

By Sjolander S.   Hansen J.-E.S.   Lovgren-Bengtsson K.   &   9kerblom L.   Morein B.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 344-352

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite

Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection

By York L.J.   Giorgio D.P.   Mishkin E.M.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1706-1712

Elsevier

Access to resources Recommend Favorite